Skip to main content

Advertisement

SpringerLink
Log in

Determinants of medication non-adherence in Egyptian patients with systemic lupus erythematosus: Sharkia Governorate

  • Original Article - Observational Research
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The aim of the study was to identify the determinants of adherence to medication among Egyptian patients with SLE. A single-center cross-sectional study was conducted among Egyptian patients with SLE. Adherence to medication was measured via The Compliance Questionnaire for Rheumatology-19, and the patients were classified as non-adherers if they were taking <80 % of their medication correctly. Predictors of adherence to SLE medication were determined by multiple logistic regressions. The mean age of participants was 30.9 ± 11.7 years. Females constituted 95 % of all participants. Thirty-eight (%) were taking <80 % of their medication correctly. On logistic regression analysis, the significant independent predictors of medication non-adherence were lower educational level (OR 5.6, 95 % CI 2.1–7.3, P < 0.001), very low and low socioeconomic status (OR 2.6, 95 % CI 1.6–4.3, P < 0.04), rural residency (OR 3.4, 95 % CI 1.4–5, P < 0.01), more number of medications (OR 3.2, 95 % CI 2.3–6.9, P < 0.01), and higher depressive symptoms (OR 3.7, 95 % CI 1.4–10.2, P < 0.001). The adherence rate reported in this study was quite low. Appropriate adherence enhancing intervention strategies targeted at reducing pill load, minimizing depressive symptoms, and ensuring an uninterrupted access to free services regimen for patients with low socioeconomic status is strongly recommended. More attention should be given to SLE patients who live in rural regions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Daleboudt GM, Broadbent E, Berger SP, Kaptein AA (2011) Illness perceptions in patients with systemic lupus erythematosus and proliferative lupus. Lupus 20(3):290–298

    Article  CAS  PubMed  Google Scholar 

  2. Kulczycka L, Sysa-Jedrzejowska A, Robak E (2009) Life satisfaction together with positive and negative aspects in Polish patients with systemic lupus erythematosus. J Eur Acad Dermatol Venereol 23(3):251–255

    Article  CAS  PubMed  Google Scholar 

  3. Navarrete-Navarrete N, Peralta-Ramírez MI, Sabio JM, Martínez-Egea I, Santos-Ruiz A, Jiménez-Alonso J (2010) Quality-of-life predictor factors in patients with SLE and their modification after cognitive behavioural therapy. Lupus 19(14):1632–1639

    Article  CAS  PubMed  Google Scholar 

  4. Isenberg D, Rahman A (2006) Systemic lupus erythematosus—2005 annus mirabilis? Nat Clin Pract Rheumatol 2:145–152

    Article  PubMed  Google Scholar 

  5. Grigor C, Capell H, Stirling A et al (2004) Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 364:263–269

    Article  PubMed  Google Scholar 

  6. Gerth WC (2002) Compliance and persistence with newer antihypertensive agents. Curr Hypertens Rep 4(6):424–433

    Article  PubMed  Google Scholar 

  7. Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353(5):487–497

    Article  CAS  PubMed  Google Scholar 

  8. Horne R (2006) Compliance, adherence, and concordance: implications for asthma treatment. Chest 130:65S–72S

    Article  PubMed  Google Scholar 

  9. Koneru S, Shishov M, Ware A et al (2007) Effectively measuring adherence to medications for systemic lupus erythematosus in a clinical setting. Arthritis Rheum 57:1000–1006

    Article  PubMed  Google Scholar 

  10. World Health Organization (2003) Adherence to long-term therapies—evidence for action. WHO Library Cataloguing-in-Publication Data, Geneva, pp 1–211

    Google Scholar 

  11. Masood S, Jayne D, Karim Y (2009) Beyond immunosuppression—challenges in the clinical management of lupus nephritis. Lupus 18(2):106–115

    Article  CAS  PubMed  Google Scholar 

  12. Pons-Estel GJ, Alarcón GS, Scofield L, Reinlib L, Cooper GS (2009) Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum 39(4):257–268

    Article  PubMed Central  PubMed  Google Scholar 

  13. Viller F, Guillemin F, Briancon S et al (1999) Compliance to drug treatment of patients with rheumatoid arthritis: a 3 year longitudinal study. J Rheumatol 26:2114–2122

    CAS  PubMed  Google Scholar 

  14. Park DC, Hertzog C, Leventhal H et al (1999) Medication adherence in rheumatoid arthritis patients: older is wiser. J Am Geriatr Soc 47:172–183

    Article  CAS  PubMed  Google Scholar 

  15. Goodacre LJ, Goodacre JA (2004) Factors influencing the beliefs of patients with rheumatoid arthritis regarding disease-modifying medication. Rheumatology (Oxford) 43:583–586

    Article  CAS  Google Scholar 

  16. Treharne GJ, Lyons AC, Hale ED et al (2006) ‘Compliance’ is futile but is ‘concordance’ between rheumatology patients and health professionals attainable? Rheumatology (Oxford) 45:1–5

    Article  CAS  Google Scholar 

  17. Tan EM, Cohen AS, Fries JF et al (1982) The revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277

    Article  CAS  PubMed  Google Scholar 

  18. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725

    Article  CAS  PubMed  Google Scholar 

  19. de Klerk E, van der Heijde D, van der Tempel H, van der Linden S (1999) Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy. J Rheumatol 14(12):2635–2641

    Google Scholar 

  20. de Klerk E, van der Heijde D, Landewe R, van der Tempel H, van der Linden S (2003) The compliance–questionnaire–rheumatology compared with electronic medication event monitoring: a validation study. J Rheumatol 14(11):2469–2475

    Google Scholar 

  21. Garcia-Gonzalez A, Richardson MG, Popa-Lisseanu M et al (2008) Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol 27(7):883–889

    Article  PubMed  Google Scholar 

  22. El-Gilany A, El-Wehady A, El-Wasify M (2012) Updating and validation of the socioeconomic status scale for health research in Egypt. East Mediterr Health J 18(9):962–968

    CAS  PubMed  Google Scholar 

  23. Bae SC, Koh HK, Chang DK, Kim MH, Park JK, Kim SY (2001) Reliability and validity of systemic lupus activity measure-revised (SLAM-R) for measuring clinical disease activity in systemic lupus erythematosus. Lupus 10:405–409

    Article  CAS  PubMed  Google Scholar 

  24. Yazdany J, Yelin EH, Panopalis P, Trupin L, Julian L, Katz PP (2008) Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort. Arthritis Rheum 59:136–143

    Article  PubMed Central  PubMed  Google Scholar 

  25. Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401

    Article  Google Scholar 

  26. Boyd JH, Weissman MM, Thompson WD, Myers JK (1982) Screening for depression in a community sample. Understanding the discrepancies between depression symptom and diagnostic scales. Arch Gen Psychiatry 39(10):1195–1200

    Article  CAS  PubMed  Google Scholar 

  27. McDowell I (2006) Measuring health: a guide to rating scales and questionnaires, vol 3. Oxford University Press, USA

    Book  Google Scholar 

  28. Martens MP, Parker JC, Smarr KL, Hewett JE, Slaughter JR, Walker SE (2003) Assessment of depression in rheumatoid arthritis: a modified version of the center for epidemiologic studies depression scale. Arthritis Rheum 49:549–555

    Article  PubMed  Google Scholar 

  29. Ghubash R, Daradkeh TK, Al Naseri KS, Al Bloushi NB, Al Daheri AM (2000) The performance of the Center for Epidemiologic Study Depression Scale (CES-D) in an Arab female community. Int J Soc Psychiatry 46(4):241–249

    Article  CAS  PubMed  Google Scholar 

  30. Chambers SA, Raine R, Rahman A, Isenberg D (2009) Why do patients with systemic lupus erythematosus take or fail to take their prescribed medications? A qualitative study in a UK cohort. Rheumatology 48(3):266–271

    Article  CAS  PubMed  Google Scholar 

  31. Sailler L, Puissant B, Méliani P et al (2007) Blood concentrations of hydroxychloroquine and its desethyl derivative correlate negatively with the percentage of CD45RO+ cells among CD4+ lymphocytes in hydroxychloroquine-treated lupus patients. Ann NY Acad Sci 1108:41–50

    Article  CAS  PubMed  Google Scholar 

  32. Julian LJ, Yelin E, Yazdany J et al (2009) Depression, medication adherence, and service utilization in systemic lupus erythematosus. Arthritis Rheum 61(2):240–246

    Article  PubMed Central  PubMed  Google Scholar 

  33. van den Bemt BJ, van den Hoogen FH, Benraad B, Hekster YA, van Riel PL, van Lankveld W (2009) Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs. J Rheumatol 3610:2164–2170

    Article  Google Scholar 

  34. Cramer J, Rosenheck R, Kirk G, Krol W, Krystal J (2003) Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes. Value Health 6:566–573

    Article  PubMed  Google Scholar 

  35. Claxton AJ, Cramer J, Pierce C (2001) A systematic review of the associations between dose regimens and medication compliance. Clin Ther 23:1296–1310

    Article  CAS  PubMed  Google Scholar 

  36. de Thurah A, Norgaard M, Harder I, Stengaard-Pedersen K (2010) Compliance with methotrexate treatment in patients with rheumatoid arthritis: influence of patients’ beliefs about the medicine. A prospective cohort study. Rheumatol Int 30(11):1441–1448

    Article  PubMed  Google Scholar 

  37. Tuncay R, Eksioglu E, Cakir B, Gurcay E, Cakci A (2007) Factors affecting drug treatment compliance in patients with rheumatoid arthritis. Rheumatol Int 278:743–746

    Article  Google Scholar 

  38. Treharne GJ, Lyons AC, Kitas GD (2004) Medication adherence in rheumatoid arthritis: effects of psychosocial factors. Psychol Health Med 93:337–349

    Article  Google Scholar 

  39. Contreras-Yanez I, De Leon SP, Cabiedes J, Rull-Gabayet M, Pascual-Ramos V (2010) Inadequate therapy behavior is associated to disease flares in patients with rheumatoid arthritis who have achieved remission with disease-modifying antirheumatic drugs. Am J Med Sci 3404:282–290

    Article  Google Scholar 

  40. Lorish CD, Richards B, Brown S (1989) Missed medication doses in rheumatic arthritis patients: intentional and unintentional reasons. Arthritis Care Res 21:3–9

    Article  Google Scholar 

  41. Salt E, Frazier SK (2010) Adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a narrative review of the literature. Orthop Nurs 29(4):260–275

    Article  PubMed Central  PubMed  Google Scholar 

  42. Lu CL, Williams KM, Day OR (2007) The funding and use of high-cost medicines in Australia: the example of anti-rheumatic biological medicines. Aust NZ Health Policy 4:1–11

    Article  Google Scholar 

  43. Potter T, Mulherin D, Pugh M (2002) Early intervention with disease-modifying therapy for rheumatoid arthritis: where do the delays occur? Rheumatology 41:953–955

    Article  CAS  PubMed  Google Scholar 

  44. Maradit-Kremers H, Nicola PJ, Crowson CS, O’Fallon WM, Gabriel SE (2006) Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis. J Rheumatol 14(2):248–255

    Google Scholar 

  45. Gehi A, Haas D, Pipkin S, Whooley MA (2005) Depression and medication adherence in outpatients with coronary heart disease: findings from the heart and soul study. Arch Intern Med 165:2508–2513

    Article  PubMed Central  PubMed  Google Scholar 

  46. Mohr DC, Goodkin DE, Likosky W, Gatto N, Baumann KA, Rudick RA (1997) Treatment of depression improves adherence to interferon β-1b therapy for multiple sclerosis. Arch Neurol 54:531–533

    Article  CAS  PubMed  Google Scholar 

  47. Wong M, Mulherin D (2007) The influence of medication beliefs and other psychosocial factors on early discontinuation of disease-modifying anti-rheumatic drugs. Musculoskelet Care 5:148–159

    Article  CAS  Google Scholar 

Download references

Conflict of interest

The authors have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Rheumatology and Rehabilitation, Zagazig University, 16 El-Emam Ali St. Villat el Jamaa, Zagazig, Egypt

    Amal B. Abdul-Sattar

  2. Department of Community, Environmental and Occupational Medicine, Zagazig University, Zagazig, Egypt

    Sahar A. Abou El Magd

Authors
  1. Amal B. Abdul-Sattar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sahar A. Abou El Magd
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amal B. Abdul-Sattar.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abdul-Sattar, A.B., Abou El Magd, S.A. Determinants of medication non-adherence in Egyptian patients with systemic lupus erythematosus: Sharkia Governorate. Rheumatol Int 35, 1045–1051 (2015). https://doi.org/10.1007/s00296-014-3182-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-014-3182-0

Keywords

Search

Navigation